Company profile
Edgewise Therapeutics, Inc. insider acquisitions
Company CIK 0001710072 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Stock awardCode A | Common StockNon-derivative · Currency not specified | 1 | Not applicable | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
6 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 1, 2026 | Edgewise Therapeutics, Inc.Common Stock | Fox Jonathan C | Stock award |
| Nov 19, 2025 | Edgewise Therapeutics, Inc.Stock Options (Right to buy) | Martin Christopher Nathan | Stock award |
| Nov 12, 2025 | Edgewise Therapeutics, Inc.Common Stock | Russell Alan J | Exercise / conversion |
| Nov 10, 2025 | Edgewise Therapeutics, Inc.Stock Options (Right to buy) | Nofi Michael | Stock award |
| Nov 10, 2025 | Edgewise Therapeutics, Inc.Restricted Stock Units | Nofi Michael | Stock award |
| Nov 11, 2025 | Edgewise Therapeutics, Inc.Common Stock | Fox Jonathan C | Purchase |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
EWTX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Fox Jonathan CDirector | Stock awardCommon StockNon-derivative security · Code A | 308 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Martin Christopher NathanDirector | Stock awardStock Options (Right to buy)Derivative security · Code A | 45,150 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Russell Alan JChief Scientific Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 100,000 | 0.18Value: 18,000Currency not specified | View ↗ |
| Trade: | Nofi MichaelChief Financial Officer | Stock awardStock Options (Right to buy)Derivative security · Code A | 262,500 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Nofi MichaelChief Financial Officer | Stock awardRestricted Stock UnitsDerivative security · Code A | 43,750 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Fox Jonathan CDirector | PurchaseCommon StockNon-derivative security · Code P | 10,700 | 18.6358 *Value: 199,403.06Currency not specified | View ↗ |
6 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →